News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,427 Results
Type
Article (41665)
Company Profile (269)
Press Release (688476)
Multimedia
Podcasts (90)
Webinars (21)
Section
Business (205401)
Career Advice (2050)
Deals (35644)
Drug Delivery (128)
Drug Development (81669)
Employer Resources (178)
FDA (16572)
Job Trends (15014)
News (347744)
Policy (32841)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2618)
Accelerated approval (43)
Adcomms (25)
Allergies (165)
Alliances (49746)
ALS (194)
Alzheimer's disease (1757)
Antibody-drug conjugate (ADC) (390)
Approvals (16907)
Artificial intelligence (610)
Autoimmune disease (235)
Automation (52)
Bankruptcy (363)
Best Places to Work (11670)
BIOSECURE Act (20)
Biosimilars (208)
Biotechnology (178)
Bladder cancer (179)
Brain cancer (66)
Breast cancer (696)
Cancer (5434)
Cardiovascular disease (458)
Career advice (1739)
Career pathing (41)
CAR-T (305)
CDC (54)
Celiac Disease (2)
Cell therapy (809)
Cervical cancer (43)
Clinical research (70494)
Collaboration (1970)
Company closure (4)
Compensation (1310)
Complete response letters (74)
COVID-19 (2736)
CRISPR (100)
C-suite (1027)
Cystic fibrosis (149)
Data (7213)
Decentralized trials (3)
Denatured (28)
Depression (154)
Dermatology (69)
Diabetes (555)
Diagnostics (6879)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (303)
Drug pricing (197)
Drug shortages (31)
Duchenne muscular dystrophy (267)
Earnings (91311)
Editorial (61)
Employer branding (22)
Employer resources (155)
Events (119009)
Executive appointments (1053)
FDA (20079)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1652)
Gene editing (214)
Generative AI (54)
Gene therapy (660)
GLP-1 (1027)
Government (4721)
Grass and pollen (6)
Guidances (400)
Healthcare (19034)
HIV (76)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (277)
Immuno-oncology (86)
Indications (163)
Infectious disease (3062)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (278)
Interviews (323)
IPO (16673)
IRA (50)
Job creations (3659)
Job search strategy (1445)
JPM (60)
Kidney cancer (19)
Labor market (95)
Layoffs (558)
Leadership (35)
Legal (7975)
Liver cancer (98)
Longevity (29)
Lung cancer (724)
Lymphoma (411)
Machine learning (54)
Management (60)
Manufacturing (957)
MASH (179)
Medical device (13963)
Medtech (14045)
Mergers & acquisitions (20149)
Metabolic disorders (1430)
mRNA (179)
Multiple sclerosis (176)
NASH (17)
Neurodegenerative disease (385)
Neuropsychiatric disorders (97)
Neuroscience (3172)
Neurotech (1)
NextGen: Class of 2026 (6540)
Non-profit (4542)
Now hiring (74)
Obesity (674)
Opinion (281)
Ovarian cancer (196)
Pain (236)
Pancreatic cancer (263)
Parkinson's disease (345)
Partnered (34)
Patents (564)
Patient recruitment (617)
Peanut (61)
People (59585)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (21974)
Phase 2 (31039)
Phase 3 (23093)
Pipeline (7430)
Policy (306)
Postmarket research (2576)
Preclinical (9343)
Press Release (64)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (310)
Rare diseases (1004)
Real estate (5989)
Recruiting (72)
Regulatory (25131)
Reports (56)
Research institute (2426)
Resumes & cover letters (355)
Rett syndrome (33)
RNA editing (18)
RSV (88)
Schizophrenia (167)
Series A (274)
Series B (205)
Service/supplier (11)
Sickle cell disease (107)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3648)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (60)
Vaccines (1064)
Venture capital (100)
Weight loss (432)
Women's health (113)
Worklife (20)
Date
Today (140)
Last 7 days (579)
Last 30 days (2616)
Last 365 days (30175)
2026 (9012)
2025 (30264)
2024 (35295)
2023 (40190)
2022 (51278)
2021 (55831)
2020 (54248)
2019 (46743)
2018 (35139)
2017 (32262)
2016 (31637)
2015 (37730)
2014 (31478)
2013 (26546)
2012 (28762)
2011 (29436)
2010 (27511)
Location
Africa (742)
Alabama (91)
Alaska (7)
Arizona (335)
Arkansas (14)
Asia (39766)
Australia (6510)
California (12474)
Canada (3578)
China (1256)
Colorado (538)
Connecticut (537)
Delaware (375)
Europe (86107)
Florida (1889)
Georgia (400)
Hawaii (3)
Idaho (63)
Illinois (995)
India (84)
Indiana (574)
Iowa (22)
Japan (505)
Kansas (129)
Kentucky (47)
Louisiana (38)
Maine (75)
Maryland (1503)
Massachusetts (8911)
Michigan (348)
Minnesota (688)
Mississippi (6)
Missouri (142)
Montana (34)
Nebraska (29)
Nevada (139)
New Hampshire (84)
New Jersey (3319)
New Mexico (28)
New York (3295)
North Carolina (1584)
North Dakota (8)
Northern California (6196)
Ohio (375)
Oklahoma (23)
Oregon (41)
Pennsylvania (2523)
Puerto Rico (28)
Rhode Island (50)
South America (1120)
South Carolina (82)
South Dakota (2)
Southern California (4898)
Tennessee (201)
Texas (1970)
United States (44216)
Utah (375)
Vermont (1)
Virginia (295)
Washington D.C. (80)
Washington State (1002)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
730,427 Results for "vascular dynamics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
April 13, 2026
·
2 min read
Press Releases
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
April 3, 2026
·
6 min read
Press Releases
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
April 16, 2026
·
6 min read
Press Releases
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
March 17, 2026
·
9 min read
Press Releases
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
March 30, 2026
·
4 min read
Press Releases
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
March 10, 2026
·
5 min read
Press Releases
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
March 30, 2026
·
9 min read
Press Releases
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 12, 2026
·
5 min read
Press Releases
Palvella Therapeutics Launches “BEYOND mLM” Disease Awareness Campaign for Microcystic Lymphatic Malformations in Collaboration with Leading Lymphatic, Vascular, and Dermatology Nonprofit Organizations
March 10, 2026
·
9 min read
Press Releases
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
March 27, 2026
·
10 min read
1 of 73,043
Next
